India’s Vaccine Giant Serum Institute Sees Yearly Sales At $500 Million Until 2015 From Global Alliance Effort
This article was originally published in PharmAsia News
Executive Summary
India’s largest vaccines manufacturer will take a big chunk of the $4.3 billion public-private global commitment to enhance vaccines access set for June this year.